Traveler’s Diarrhea

  • Alexa R. GaleEmail author
  • Matthew Wilson


The world is now a smaller place, where international travel is feasible and accessible to a large population. Traveler’s diarrhea (TD) is a clinical syndrome of diarrhea, abdominal pain, fever, vomiting, and bloody diarrhea within 2 weeks of travel. The CDC estimates that TD affects 30–70% of travelers. There are several categories of traveler’s diarrhea: mild, moderate, severe, and persistent. The highest-risk areas for TD are Asia, the Middle East, Africa, Mexico, Central America, and South America. Bacterial pathogens are responsible for 80–90% of TD cases.


Traveler’s diarrhea Loperamide Diarrhea Dehydration Abdominal pain Antibiotics 


  1. 1.
    Connor B. Travelers’ health [document on internet]. 2017 June 13 [cited 2018 January 16]. Available from
  2. 2.
    Steffen R, Hill DR, Dupont HL. Traveler’s diarrhea. A clinical review. JAMA. 2015;313(1):71–80.CrossRefGoogle Scholar
  3. 3.
    Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, et al. Treatment of traveler’s diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide and loperamide alone. Clin Gastroenterol Hepatol. 2007;5(4):451–6.CrossRefGoogle Scholar
  4. 4.
    Dupont HL, Ericsson C, Farthing M, Gorbach S, Pickering LK, Rombo L, et al. Expert review of the evidence base for self-therapy of traveler’s diarrhea. J Travel Med. 2009;16(3):161–71.CrossRefGoogle Scholar
  5. 5.
    Riddle MS, Connor P, Fraser J, Porter CK, Swierczewski B, Hutley EJ, et al. Trial evaluating ambulatory therapy of travelers’ diarrhea (TrEAT TD) study: a randomized controlled trial comparing 3 single-dose antibiotic regimens with loperamide. Clin Infect Dis. 2017;65(12):2008–17.CrossRefGoogle Scholar
  6. 6.
    Tribble DR, Sanders JW, Pang LW, Mason C, Pitarangsi C, Bagar S, et al. Traveler’s diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin- based regimens with a 3-day levofloxacin regimen. Clin Infect Dis. 2007;44(3):338–46.CrossRefGoogle Scholar
  7. 7.
    Woerther P, Andremont A, Kantele A. Travel acquired ESBL-producing enterobacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017;24(1):S29–34.CrossRefGoogle Scholar
  8. 8.
    Connor B. Travelers’ Health. 2017. Retrieved January 16, 2018, from
  9. 9.
    Riddle MS, Connor BA, Beeching NJ, DuPont HL, Hamer DH, Kozarsky P, Libman M, Steffen R, Taylor D, Tribble DR, Vila J, Zanger P, Charles D. Ericsson; Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report. J Travel Med. 2017;24(suppl_1):S63–80. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Georgetown University School of Medicine, MedStar Washington Hospital Center, Department of Emergency MedicineWashington, DCUSA

Personalised recommendations